Lyra Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.338; its P/E ratio is -4.03; Lyra Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 146.00K	$ 544.00K	$ 458.00K	$ 410.00K	$ -4.77M
Gross Profit	$ 146.00K	$ 544.00K	$ 458.00K	$ 410.00K	$ -4.77M
EBIT	$ -15.19M	$ -15.63M	$ -15.61M	$ -16.24M	$ -19.94M
EBITDA	$ -15.19M	-	$ -16.25M	$ -16.68M	$ -20.16M
Net Income Common Stockholders	$ -15.18M	$ -15.65M	$ -15.62M	$ -16.25M	$ -19.00M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 102.75M	$ 102.55M	$ 116.45M	$ 82.71M	$ 97.85M
Total Assets	$ 142.60M	$ 120.58M	$ 125.67M	$ 93.87M	$ 109.97M
Total Debt	$ 26.88M	$ 6.29M	$ 1.69M	$ 2.09M	$ 2.22M
Net Debt	$ -75.87M	$ -96.26M	$ -114.77M	$ -80.62M	$ -95.63M
Total Liabilities	$ 53.18M	$ 36.34M	$ 27.10M	$ 27.78M	$ 29.21M
Stockholders Equity	$ 89.42M	$ 84.24M	$ 98.63M	$ 66.09M	$ 80.75M
Cash Flow	-
Free Cash Flow	$ -19.84M	-	$ -14.35M	$ -15.89M	$ -12.19M
Operating Cash Flow	$ -19.06M	$ -14.11M	$ -14.28M	$ -15.85M	$ -12.16M
Investing Cash Flow	$ -2.36M	$ -14.98M	$ -561.00K	$ 5.32M	$ -64.87M
Financing Cash Flow	$ 18.92M	$ -418.00K	$ 47.19M	$ 4.00K	-

Currency in USD

Lyra Therapeutics Earnings and Revenue History

Income Statement >

Lyra Therapeutics Debt to Assets

Balance Sheet >

Lyra Therapeutics Cash Flow

Cash Flow >

Lyra Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing